Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002786 300049 300713 China Securities China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Shandong Lukang Pharmaceutical Shenzhen Silver Basis Technology Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Regulations Accounting, Audit Management Stock Option Annual, Special Corporate Meeting Annual Report Board Of Directors Research, Development Construction, Property Electricity Production, Distribution Financial, Business Service Gold, Precious Material Market, Exchange Loans Securities Diseases, Conditions Medicine Exercise, Fitness

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network